Serum and Biliary Insulin-like Growth Factor I As A Diagnostic Marker for Cholangiocarcinoma
Labib Abbas Hafez;
Abstract
Cholangiocarcinoma (CCA) accounts for 3% of gastrointestinal tumors. It is the 2nd most common primary hepatic malignancy, representing 10–25% of primary hepatic malignancies worldwide. During the last decade, an increased incidence of intrahepatic CCA ve
Other data
| Title | Serum and Biliary Insulin-like Growth Factor I As A Diagnostic Marker for Cholangiocarcinoma | Other Titles | قياس نسبة معامل النمو شبيه الإنسولين (1) فى الدم والعصارة الصفراوية كتحليل تشخيصى لمرضى سرطان القنوات المرارية | Authors | Labib Abbas Hafez | Keywords | Serum and Biliary Insulin-like Growth Factor I As A Diagnostic Marker for Cholangiocarcinoma | Issue Date | 2014 | Description | Cholangiocarcinoma (CCA) accounts for 3% of gastrointestinal tumors. It is the 2nd most common primary hepatic malignancy, representing 10–25% of primary hepatic malignancies worldwide. During the last decade, an increased incidence of intrahepatic CCA ve |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 119864All Thesis.pdf | 339.49 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.